BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 15, 2008
View Archived Issues
Novel series of histamine H3 receptor inverse agonists disclosed by Banyu and Merck
Read More
Drospirenone evaluated as antiadipogenic agent in preclinical studies
Read More
Phase I studies demonstrate proof-of-concept for REG1 anticoagulation system
Read More
AdVEGF121 BIOBYPASS gene therapy not beneficial in advanced coronary artery disease
Read More
DU-176b prevents venous thromboembolism in patients undergoing total hip replacement
Read More
Orexo and Boehringer extend research collaboration in pain and inflammation
Read More
Cubist presents update on acute care product pipeline
Read More
Recent patents describe new antipsychotic and antidepressant agents
Read More
Nabi and the NIAID enter collaboration to advance PentaStaph S. aureus vaccine
Read More
Novel anticancer agents disclosed in recent patent literature
Read More
Novel treatment options for gastrointestinal disorders reported in recent patents
Read More
Allergan and Asterand sign exclusive license agreement for preclinical compounds for eye diseases
Read More
ImVision starts enrollment in phase I IVN-201 trial for cat dander allergy
Read More
Proteon receives FDA fast track designation for PRT-201
Read More
TopoTarget reports phase II belinostat data in cutaneous lymphomas and ovarian cancer
Read More
FDA grants priority review to Novartis' Afinitor and MAA filed with EMEA and Swissmedic
Read More
Addex has reported results from phase II studies of ADX-10059
Read More
Hana achieves response criteria to proceed to full enrollment in rALLy clinical trial of Marqibo
Read More
Cellzome and GSK sign worldwide strategic alliance for kinase-targeted therapeutics
Read More
Bayer signs licensing agreement with Nagasaki University to use tracers in PET in AD
Read More
CVBT opens first U.S. enrollment site in phase II clinical trial of FGF-1 in heart disease
Read More
RiskMetrics approves Roche's planned acquisition of Arius Research's outstanding shares and warrants
Read More
Pluristem reports results from preclinical safety studies in animals of PLX-PAD in CLI
Read More
Solvay acquires Innogenetics for EUR 200.7 million in cash
Read More